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Abstract 21 
Paraquat, a common herbicide, is responsible for large numbers of deaths worldwide 22 
through both deliberate and accidental ingestion.  Previous studies have eluded that the 23 
bioavailability of paraquat increases substantially with increasing dose and that these 24 
changes may in part be due to the effects these high concentrations have on the 25 
gastrointestinal tract (GI tract). To date, the actions of acute, high concentrations (20 26 
mM for 60 minutes) of paraquat on the GI tract, particularly the colon a major site of 27 
paraquat absorption, are unknown.  This study examined the effects of acute paraquat 28 
administration on colonic motility in the C57BL/6 mouse.  Acute paraquat exposure 29 
decreased colonic motility and the amplitude of colonic migrating motor complexes 30 
(CMMCs), major motor patterns involved in faecal pellet propulsion.  In isolated 31 
segments of distal colon, paraquat increased resting tension and markedly attenuated 32 
electrical field stimulation-evoked relaxations.  Pharmacological dissection of paraquat’s 33 
mechanism of action on both the CMMCs and field stimulated tissue using the nitric 34 
oxide synthase inhibitor NG-nitro-L-Arginine and direct measurement of NO release 35 
from the myenteric plexus, demonstrated that paraquat selectively attenuates nitrergic 36 
signaling pathways.  These changes did not appear to be due to alterations in colonic 37 
oxidative stress, inflammation or complex 1 activity, but were most likely caused by 38 
paraquat’s ability to act as a redox couple.  In summary, these data demonstrate that 39 
acute paraquat exposure attenuates colonic transit.  These changes may facilitate the 40 
absorption of paraquat into the circulation and so facilitate its toxicity.   41 
Key words: Colon motility, Colonic Migrating Motor Complex, Paraquat and Nitric 42 
Oxide.43 
3 
 
1. Introduction 44 
Paraquat is a widely used herbicide responsible for large numbers of deaths worldwide.  45 
Paraquat bioavailability is normally low (Chui et al., 1988; Gawarammana et al., 2011; 46 
Kan et al., 2010) but increases substantially with increasing doses, potentially due to 47 
effects on the colon a major site of paraquat absorption (Gawarammana et al., 2011).  48 
As reduced motility may provide a mechanism to facilitate paraquat absorption and 49 
increase its bioavailability, we have chosen to examine the effects of paraquat on 50 
colonic motility. 51 
Motility involves coordinated muscle contractions/relaxations.  Contraction is driven by 52 
activity in excitatory motor neurons that release acetylcholine and tachykinins (Gamage 53 
et al., 2013; Wade et al., 2004).  Relaxation involves the activation of inhibitory motor 54 
neurons which release a combination of nitric oxide a purine (ATP or β-NAD) and 55 
vasoactive intestinal peptide (Akbulut et al., 2015; Cowen, 2000; Patel et al., 2014; 56 
Thrasivoulou et al., 2006).  Changes in the balance between contraction and relaxation 57 
can lead to an impairment of motility. 58 
Paraquat can alter cellular and organ function in a variety of ways. It is a pro-oxidant 59 
that generates the superoxide free radical (Day et al., 1999) and has been used to 60 
induce oxidative stress in a wide range of tissues/cell types to mimic disease (Bove et 61 
al., 2012; Djukic et al., 2012; Drechsel et al., 2008; McCormack et al., 2005; Miller et al., 62 
2009; Samai et al., 2008)  and to examine the role of oxidative stress in the natural 63 
ageing process (Jung et al., 2009; Salmon et al., 2009; Van Raamsdonk et al., 2009).  64 
Paraquat also reduces the activity of protein complexes of the respiratory chain 65 
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(Cocheme et al., 2008; Gomez et al., 2007; Rodriguez-Rocha et al., 2013) and can 66 
induce inflammation (Aires et al., 2013; Ajjuri et al., 2013; Bove et al., 2012). 67 
This study examined the effect of paraquat on colonic motility and its mechanism of 68 
action.  69 
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2. Materials and Methods 70 
2.1 Animals 71 
All procedures were carried out according to U.K. Animals (Scientific Act), 1986 and 72 
associated guidelines and were approved by the University of Brighton Ethics 73 
Committee.  Male C57BL/6J mice were obtained from Harlan UK at 8 weeks of age and 74 
housed in groups of 3-4 until required.  Animals were maintained at 19.0 ± 1 °C, 55 % 75 
humidity and fed on a maintenance diet (RM1 (E) 801002 chow, Special Diet Services) 76 
and had free access to water.  The animals were kept on a 12 hour light/dark cycle and 77 
studied at 3-4 months of age. Mice were killed prior to experimentation by CO2 (100%) 78 
asphyxiation, followed by cervical dislocation. 79 
2.2 Pellet motility assays 80 
The whole colon was harvested and placed in ice cold oxygenated (95% O2 and 5% 81 
CO2) Krebs buffer solution, pH 7.4 containing (117 mM NaCl, 4.7 mM KCl, 2.5 mM 82 
CaCl2, 1.2 mM MgCl2, 1.2 mM NaH2PO4, 25 mM NaHCO3, and 11 mM glucose).  The 83 
mesentery was trimmed using fine scissors and the whole colon was then loosely 84 
pinned in a Sylgard-lined flow bath, allowing a lateral movement of approximately 0.5 85 
cm about the mid-line and perfused with oxygenated Krebs buffer solution at 37 ± 1 °C 86 
at a flow rate of 8 ml min-1.  A small (2 mm) incision was made in both ends of the colon 87 
and the openings pinned flat to facilitate pellet insertion and its expulsion at the distal 88 
end.  If spontaneous evacuation was not achieved, the faecal pellets were removed 89 
from the isolated colon after 30 minutes, by gently flushing the lumen of the colon with 90 
warmed Krebs buffer solution.  The colon was then left to stabilize for 15 minutes, prior 91 
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to recordings of pellet motility. Measurements of motility were carried out using a 2mm 92 
diameter epoxy-coated artificial faecal pellet.  The artificial faecal pellet was inserted 3-4 93 
mm into the proximal end of the bowel using a fire-polished glass capillary and the 94 
movement of the pellet was monitored using a video camera.  Pellet motility was 95 
tracked using Ethovision tracking software.  Following a successful trial, the experiment 96 
was repeated two further times and the average response utilized for statistical analysis. 97 
Tissues were then perfused with 20 mM paraquat for 60 minutes and pellet motility 98 
assayed for a further three trials.  The maximum time that any single trial was 99 
conducted was 45 minutes.  The total transit time of the artificial faecal pellet was 100 
recorded along with the distance and the average velocity of the pellet determined 101 
(Patel et al., 2014). 102 
2.3 Measurement of Colonic Migrating Motor Complexes (CMMCs) 103 
Briefly the whole colon was placed in a Sylgard-lined recording chamber and a thin 104 
metal rod (1 mm diameter) placed through the lumen and secured at each end to the 105 
Sylgard.   Recordings of circular muscle contractions were made at two locations along 106 
the whole isolated colon, one at the proximal end and one at the distal end.  Fine suture 107 
silk was tied through the muscle layers at each location and connected to two separate 108 
isometric force transducers.  The muscle was placed initially under a low level of tension 109 
4 mN and then tension increased over the next 40 minutes until a final tension of 6 mN 110 
was reached.  The signal from each force transducer then passed to a preamplifier and 111 
ADI Powerlab before being stored on computer using Chart software.  The tissue was 112 
perfused for 60 minutes prior to recording with either normal Krebs buffer solution or 113 
Krebs buffer solution containing 20mM paraquat.  Post this period, recordings of 114 
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spontaneous CMMCs were made for 60 minutes before the addition of 100 µM NG-115 
nitro-L-Arginine (nitric oxide synthase inhibitor).  The bath was allowed to equilibrate for 116 
30 minutes with the NG-nitro-L-Arginine before spontaneous CMMCs were again 117 
recorded for 60 minutes.  118 
2.4 Electrical field stimulated distal colon segments 119 
The whole colon was removed and 2 cm sections of distal colon were hung vertically in 120 
an organ bath containing Krebs buffer solution.  Distal colon segments were chosen as 121 
their pharmacology in mice is far better understood than the proximal colon. Tissues 122 
were then incubated for 60 minutes in either control Krebs buffer or Krebs buffer 123 
containing 20mM paraquat.  At the end of this period the tissue was washed 4 times 124 
and 10 µM guanethidine added to the bath.  The tissue was then dosed up with 100 µM 125 
acetylcholine for 1 minute every 10 minutes, until successive applications yielded a 126 
consistent response.  Following this a frequency response curve was generated by 127 
passing current pulses across the tissue (40 V, 0.3 ms pulse duration, 0.1-30 Hz).  128 
Tissues were stimulated for 30 s every 5 minutes.   The tissues were then washed and 129 
the frequency response curves repeated in the presence of  either 100 µM NG-nitro-L-130 
Arginine or 1 µM scopolamine (muscarinic antagonist) + 1µM GR159897 (NK2 receptor 131 
antagonist) to block contractile pathways.   132 
Responses to EFS can be obtained through activation of neurons within the plexi or 133 
directly through activation of the smooth muscle. To ensure our protocol was selectively 134 
activating neurons 400 nM tetrodotoxin was added to the tissue to block neuronal 135 
voltage –gated Na+ channels and the tissue again stimulated at 10 Hz. 136 
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2.5 Detection of NO release from the myenteric plexus 137 
Methods for the detection of NO release from the myenteric plexus have been 138 
described previously (MacEachern et al., 2011; Patel et al., 2010). 10µM veratridine 139 
(Na+ channel activator) was used to evoke NO release to mimic the effects of electrical 140 
field stimulation. 141 
For the following assays freshly isolated distal colonic segments were placed in either 142 
Krebs buffer solution or Krebs buffer solution containing 20 mM paraquat for 60 143 
minutes.  Following the incubation the tissues were washed and the colon bisected 144 
along the mesenteric border to expose the mucosal tissue, which was then scraped 145 
away.  The mucosa and remaining muscle layers were then stored separately. 146 
2.6 Malondialdehyde assay 147 
Malondialdehyde formation was utilized to quantify levels of lipid peroxidation in the 148 
tissue samples and measured as thiobarbituric acid-reactive material.  Tissues were 149 
homogenized (100 mg ml-1) in 1.15% KCl buffer.  200 µl of the homogenates were then 150 
added to a reaction mixture consisting of 1.5 ml 0.8% thiobarbituric acid, 200 µl 8.1% 151 
sodium dodecyl sulfate, 1.5 ml 20% acetic acid (pH 3.5) and 600µl distilled H2O.  The 152 
mixture was then heated at 90 °C for 45 minutes.  After cooling to room temperature, 153 
the samples were cleared by centrifugation (10000g, 10 minutes) and their absorbance 154 
measured at 532 nm, using 1, 1, 3, 3-tetramethoxypropane as an external standard. 155 
The level of lipid peroxides was expressed as nmol MDA /mg protein (Bradford assay). 156 
2.7 Western Blot 157 
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The mucosa and remaining muscle layers were separately snap frozen in liquid N2 for 158 
storage.  Tissue was placed on ice in lysis buffer (10 mM HEPES, 150 mM NaCl, 1mM 159 
EDTA, 0.2 % Nonidet P40, protease inhibitor cocktail P8340, Sigma-Aldrich Inc.) and 160 
manually lysed.  Lysates were centrifuged for 10 minutes, at 4 °C at 700 x g to pellet 161 
debris and nuclear components.  Supernatants were removed and their protein content 162 
assessed using Quick Start Bradford Dye reagent (Bio-Rad) 26.  15 µg of protein from 163 
each sample was combined with an equal volume of 2 x Laemmli loading buffer (S3401, 164 
Sigma Aldrich), separated on a 10 % SDS-PAGE gel using the Mini-protean II 165 
electrophoresis cell (Bio-Rad) and transferred to Immobilon polyvinylidene fluoride 166 
(PVDF) membrane using the Trans-Blot® wet transfer (Bio-Rad).  Membranes were 167 
blocked with 5 % milk in PBS-Tween 20 (0.2 %) for 3 hours and then incubated 168 
overnight at 4 °C with either a rabbit anti-TNFα antibody (1:5000; Millipore) or a rabbit 169 
anti-complex 1 antibody (1:5000; Aviva systems) or a mouse monoclonal anti-actin 170 
antibody (1:5000; Santa Cruz) diluted in milk-PBS-Tween 20.  Membranes were 171 
washed five times in PBS-Tween 20 and then incubated with goat anti-rabbit HRP-172 
conjugated secondary antibody at 1:2000 (SC-2005, Santa Cruz Biotechnology) or a 173 
goat anti-mouse HRP-conjugated secondary (1:2500) for 1 hr at room temperature.  174 
After five further washes with PBS-Tween 20, membranes were treated with 175 
Amersham™ ECL plus western blotting detection system (GE Healthcare) and exposed 176 
to Amersham™ ECL plus film.  The relative intensity of each SERT band was measured 177 
by densitometry using the Fluorochem™ imager (Alpha Innotech) and the signal was 178 
normalized to the density of the corresponding actin labelled band. 179 
2.8 Complex 1 assay 180 
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A complex I enzymatic activity microplate assay kit (Mitoscience, Eugene, Oregon) was 181 
used to determine the activity of the complex I.  Briefly, mitochondrial OXPHOS 182 
Complex I was immunocaptured and the activity was determined at 450 nm by following 183 
the oxidation of NADH to NAD+.  Total protein in the mitochondrial fraction was 184 
estimated using a protein assay kit (Bradford). 185 
 186 
2.9 Data Analysis 187 
Pellet velocities were calculated by calculating the distance moved in 500 s.  CMMC 188 
parameters were calculated as follows.  Amplitude was determined by measuring the 189 
change in tension from the trough to peak of the CMMC.  Duration represented the 190 
width of the CMMC at baseline in seconds.  Velocity was determined by calculating the 191 
time from the peak of the CMMC in the proximal colon to the peak of the CMMC in the 192 
distal colon and dividing it by the distance between the two transducers.  Values for 193 
each of these three parameters were obtained for at least 6 CMMCs and averaged to 194 
give a mean value for each tissue.  CMMC frequency was determined by calculating the 195 
time taken for 6 spontaneous CMMCs and dividing by 6.  196 
 197 
In experiments that examined the effects of paraquat on electrical field stimulation 198 
evoked colonic responses, alterations in resting tension were determined during the 199 
initial 60 minute stabilization period when the tissues were either bathed in Krebs buffer 200 
solution or Krebs buffer solution containing 20 mM paraquat. Tension changes were 201 
determined by measuring the difference in baseline tension at time zero from that at 202 
time 60 minutes.  The number of contractions per 10 minutes was determined by 203 
11 
 
counting the number of phasic contractions that occurred during the final 10 minutes of 204 
the 60 minute stabilization period.  Results from the electrical field stimulation tissue 205 
experiments are plotted as the integral of the response calculated during the 30 second 206 
stimulation period using GraphPad Prism and averaging the responses from the 5 207 
preparations.  Statistical analysis of the pellet motility, resting tension and number of 208 
contractions per minute, the analysis of malondialdehyde levels and the Western blots 209 
were compared using an unpaired t-test.  Changes in NO release were compared using 210 
a paired t-test. CMMC responses were compared using a 1 way ANOVA with a post-211 
hoc Tukey test.  Electrical field stimulation -evoked responses were analyzed using a 212 
two-way ANOVA with frequency and paraquat as the two variables.  Post hoc analysis 213 
was carried out using a Tukey test.  All data are expressed as the mean±SEM and 214 
p<0.05 was taken as significant. 215 
 216 
  217 
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3. Results 218 
Isolated full thickness segments of distal colon maintained in Krebs buffer slowly 219 
relaxed over a 60 minute period to a stable resting tension (Fig 1Ai).  In the presence of 220 
paraquat tissues showed a significant increase in both the resting tension (Fig 1Aii/B) 221 
and the number of large amplitude spontaneous contractions per 10 minutes (Fig 222 
1Aii/C).  Field stimulation evoked a relaxation of untreated tissue at frequencies 223 
between 1-10 Hz (Fig 2Ai/Aiii).  However, a marked contraction was observed in 224 
paraquat-treated tissue stimulated over the same frequency range (Fig. 2 Aii/Aiii; 225 
p<0.001, 2-way ANOVA).  Application of L-NNA to block nitrergic signaling the main 226 
component of the relaxation response led to a contractile response being recorded in 227 
both treated and untreated tissues that were not significantly different (Fig 2B).  In a 228 
similar series of experiments blockade of the contractile component of the response 229 
with a mixture of scopolamine and GR159897, increased the amplitude of the relaxation 230 
seen in untreated tissue (Fig 2Ci/Ciii), but completely blocked the response of the 231 
paraquat-treated tissue to field stimulation (Fig 2Cii/Ciii; p<0.001, 2-way ANOVA).  No 232 
electrical field stimulation-evoked responses were observed in the presence of TTx 233 
confirming our stimulation protocol was selectively activating neurons (data not shown).  234 
These data strongly suggested that paraquat was inhibiting electrical field stimulation -235 
evoked nitrergic signaling without affecting the contractile component of the response. 236 
In order to test whether paraquat treatment also affected motility we examined the 237 
effects of paraquat on CMMCs a major motor pattern involved in pellet motility.  CMMCs 238 
are propagating waves of contraction that typically travel in an oral to anal direction 239 
down the colon.  In control preparations 80% of recorded CMMCs from 6 preparations 240 
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migrated in an oral to anal direction with the remaining 20% being uncoordinated.  In 241 
paraquat-treated tissue only 50% of CMMCs moved in an oral to anal direction with 20 242 
% moving in a retrograde direction and 30 % being uncoordinated.  The changes 243 
observed with paraquat were similar to those seen with L-NNA where 40% moving in an 244 
oral to anal direction, with 20% moving in a retrograde direction and 40% being 245 
uncoordinated.  Pre-treatment with paraquat caused a significant decrease in the 246 
amplitude of spontaneous CMMCs in both the proximal and distal colons (p<0.05; Fig 247 
3A/Bi/Ci).  Paraquat reduced the duration of CMMC in the distal colon (p<0.05) but was 248 
without effect on the duration of the proximal colon (Fig 3Bii/Cii).  The frequency of 249 
CMMCs was increased following paraquat application (p<0.05; Fig 3D), although there 250 
was no change in the velocity (Fig. 3E).  Subsequent application of L-NNA following 251 
paraquat treatment failed to evoke any additional changes.  Based on the EFS data 252 
shown above, one possible explanation for these data was that paraquat was blocking 253 
the L-NNA sensitive nitrergic component of the colonic migrating motor complexes.  To 254 
test this hypothesis, the effects of L-NNA administration on the properties of CMMCs 255 
were examined in a separate series of experiments.  L-NNA decreased CMMC 256 
amplitude (Fig 4A; p<0.05), distal duration (Fig 4B; p<0.05) and increased CMMC 257 
frequency (Fig 4C; p<0.05), without affecting velocity (Fig 4D), changes that were 258 
consistent with paraquat inhibiting nitrergic signaling. 259 
We next examined whether paraquat altered the migration velocity of an artificial faecal 260 
pellet placed in ex vivo full length colons.  All colons examined completely evacuated 261 
their natural pellets within 30 minutes (n=4).  Under control conditions the 2 mm artificial 262 
pellet moved in a stepwise manner along the colon (Fig 5Ai; black lines), with a mean 263 
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velocity of 0.73 ± 0.23 cm min-1 (Fig 5Aii).  Addition of paraquat inhibited stepwise 264 
movements of the pellet (Fig 5Ai; grey lines) and significantly reduced mean velocity to 265 
0.004 ± 0.008 cm min-1 (p<0.01; Fig 5Aii). 266 
To examine whether paraquat inhibited NO production, amperometric measurements 267 
were made from the myenteric plexus following application of veratradine a voltage-268 
gated Na+ channel agonist.  Application of paraquat was observed to cause a significant 269 
decrease in the amperometric current (Fig 6A/B). 270 
In order to examine the mechanism by which acute paraquat treatment reduced colonic 271 
motility we examined whether the observed effects were linked to changes in oxidative 272 
stress, complex 1 expression/activity or the production of TNFalpha a pro-inflammatory 273 
mediator.  These putative mechanisms of action were chosen as chronic paraquat has 274 
previously been shown to evoke these changes in other systems.  These experiments 275 
were carried out solely on the distal colon segments to ensure consistency with the EFS 276 
data.  A determination of MDA levels, a marker of lipid peroxidation, in both the mucosa 277 
and muscle of the distal colon showed that paraquat pretreatment increased levels of 278 
MDA in the mucosa but was without significant effect in the muscle (Fig 1 suppl.), 279 
strongly suggesting that oxidative stress was not responsible for the observed changes 280 
in muscle function. 281 
Analysis of levels of the cytokine, TNFα, a marker of cellular inflammation demonstrated 282 
a non-significant decrease in levels in both the mucosa and muscle samples (Fig 2A 283 
suppl.), suggesting that the observed changes in function were not caused by increases 284 
in inflammation.  Finally the expression and activity of Complex 1 was examined.  285 
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Western blot analysis showed no significant changes in the expression of Complex 1 in 286 
both the mucosa and muscle samples from the distal colon (Fig 2B suppl).  287 
Measurements of complex 1 activity also failed to show a significant change following 288 
paraquat pre-treatment (data not shown). 289 
  290 
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4. Discussion 291 
The current study has shown that acute paraquat treatment can reduce colonic motility 292 
in the mouse.  To our knowledge this is the first report of paraquat affecting GI tract 293 
motility.  The colon has previously been shown to be a major route by which paraquat is 294 
absorbed into the blood stream and a reduction in lower bowel motility would increase 295 
the time that paraquat spends in the lower bowel facilitating its absorption, its 296 
bioavailability and the potential for toxicity. 297 
4.1 Paraquat selectively inhibits nitrergic signaling pathways in colonic smooth muscle. 298 
Several lines of evidence strongly infer that these changes are due to paraquat 299 
inhibiting NO signaling in the colon.  First, in isolated segments of full thickness colon 300 
application of paraquat was capable of increasing the resting tension of the muscle and 301 
inhibiting field stimulated relaxations, effects that were mimicked by pretreatment with L-302 
NNA (Dickson et al., 2010).  Second, pretreatment with paraquat increased the 303 
frequency and decreased the amplitude of the CMMCs, changes that could be 304 
mimicked by the application of L-NNA a NOS inhibitor.  In support of this observation, a 305 
previous study has shown similar changes in the properties of the CMMCs in wild type 306 
mice following application of L-NNA (Duncan et al., 2013; Mawe et al., 2006).   Third, 307 
we have shown that acute paraquat treatment can inhibit pellet motility.  Although we 308 
have not demonstrated that this is due directly to paraquat inhibiting nitrergic signaling, 309 
the results are consistent with previous studies that have demonstrated that application 310 
of L-NNA was able to reduce pellet motility in an intact but isolated colon consistent with 311 
the results of the current study (Fida et al., 1997; Mawe et al., 2006).  Similarly, in NOS-312 
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/- mice, pellet motility has also been shown to be inhibited (Coates et al., 2004; Mawe et 313 
al., 2006).  These changes were shown to be due to L-NNA removing a tonic inhibition 314 
from the muscle allowing the muscle cells to depolarize which in turn caused CMMCs to 315 
become uncoordinated or to travel in a retrograde direction.  Paraquat caused similar 316 
changes to CMMC migration in the current study and these, together with a marked 317 
decrease in CMMC amplitude were most likely responsible for the decrease in pellet 318 
motility despite a lack of change in CMMC velocity. 319 
To identify the site of action of paraquat we used amperometric measurements and 320 
demonstrated that paraquat almost completely inhibited NO release from the myenteric 321 
plexus.  Paraquat has been shown to cause muscle relaxation through the activation of 322 
soluble guanylate cyclase and activation of SK channels. It is possible that paraquat 323 
could also be interfering with postsynaptic signal transduction pathways; however, the 324 
almost complete inhibition of NO release suggests that if this is the case then it is a 325 
minor component of paraquats’ effect on the colon. 326 
4.2 How does paraquat attenuate NO release? 327 
Previous studies have shown that paraquat is capable of inducing oxidative stress in 328 
tissues and this has been shown to be the main way in which it exerts its toxicity in 329 
humans (Dinis-Oliveira et al., 2008; Drechsel et al., 2008).  However, it is difficult to see 330 
how the observed selectivity for nitrergic signaling can be explained by this mechanism.  331 
Analysis of MDA levels, a marker of lipid peroxidation, failed to show any significant 332 
changes in the colonic smooth muscle, although significant increases were observed in 333 
the mucosa.  Previous studies have demonstrated that signaling via the mucosa is an 334 
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important regulator of pellet motility and CMMCs, providing the possibility that the 335 
observed increases in oxidative stress could affect pellet motility (Bischoff et al., 2009; 336 
Ghia et al., 2009).  However, mucosal signaling pathways affect both the contractile and 337 
relaxation pathways and therefore the increase in mucosal oxidative stress is unlikely to 338 
provide an explanation for the selective attenuation of nitrergic signaling pathways 339 
(Idzko et al., 2004; Margolis et al., 2014).  Based on these data it is unlikely that 340 
oxidative stress is the main cause of the changes observed in this study.  Paraquat can 341 
also induce inflammation through the production of a range of cytokines including 342 
TNFalpha and these changes could contribute to the attenuation in nitrergic signaling 343 
(Aires et al., 2013; Amirshahrokhi, 2013).  Expression of the pro-inflammatory cytokine, 344 
TNFalpha was reduced non-significantly in the both the mucosa and muscle, 345 
inconsistent with inflammation driving the observed changes in signaling. Finally, 346 
paraquat has previously been shown to interfere with the activity of Complex 1 a 347 
respiratory chain enzyme (Choi et al., 2008; Cocheme et al., 2008; Rodriguez-Rocha et 348 
al., 2013).  However, pretreatment with paraquat failed to alter both the expression and 349 
activity of the enzyme negating this as a possible mechanism of action. 350 
The lack of any significant changes in these pathways is probably indicative of the 351 
relatively short period that the tissue was exposed to paraquat (60 minutes).  In the light 352 
of these findings a single previous study by Day et al has inferred an alternative 353 
mechanism that may help explain how paraquat selectively suppresses NO signaling 354 
pathways in the colon (Day et al., 1999). Nitric oxide selectively oxidises L-arginine to 355 
yield L-citrulline and the free radical gas NO.  An additional byproduct of this reaction is 356 
the superoxide anion.  The authors showed that in the presence of paraquat the NOS 357 
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enzyme was capable of generating a paraquat free radical demonstrating that NOS 358 
shunts electrons to paraquat, thereby uncoupling the enzyme and inhibiting NO 359 
production (Day et al., 1999; Moran et al., 2010).  The reduction in NO production was 360 
shown to be associated with an increased production of the superoxide anion and the 361 
consequential production of hydrogen peroxide.  This provides a mechanism by which 362 
paraquat could increase oxidative stress.  Our lack of an observed change in the 363 
oxidative stress marker MDA could be due to the limited time period that tissue was 364 
exposed to paraquat or could be due to the fact that the changes were initially limited to 365 
a subset of neurons in the colon causing paraquats’ effect to be diluted out by a lack of 366 
lipid peroxidation in the bulk tissue. 367 
 4.3 Conclusions 368 
We have demonstrated that acute pre-treatment with high doses of paraquat is capable 369 
of inhibiting colonic transit and that these changes do not appear to reflect appropriate 370 
alterations in oxidative damage, inflammation or Complex 1 activity.  These short-term 371 
changes most likely reflect the ability of paraquat to inhibit the production of NO by 372 
acting as a redox couple.  These data are important as they suggest that agents 373 
designed to relax GI smooth muscle such as VIP or the purine ATP or β-NAD may be 374 
useful targets to help maintain normal colonic movements in conditions of paraquat 375 
poisoning.  Additionally, many studies in cell culture routinely use short duration 376 
administration of high concentrations of paraquat as a means of inducing oxidative 377 
stress and cell damage in an attempt to either mimic disease or the ageing process.  It 378 
is clear that caution needs to be taken when interpreting these results as it is possible 379 
that any short-term changes that are observed maybe happening in the absence of 380 
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oxidative stress or at least may be a combination of oxidative stress and an inhibition of 381 
nitrergic signaling. 382 
  383 
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Figure Legends 534 
Figure 1: Paraquat increases resting tension in murine distal colon.  Sample traces of 535 
the force generated by isolated segments of distal colon maintained in Krebs buffer 536 
solution (Ai) or Krebs buffer solution containing 20mM paraquat (Aii).  Bar graphs 537 
illustrating that paraquat increases resting tension (B) and the number of phasic 538 
contractions per minute (C) of distal colon segments. N=6 for each group; ***P<0.001. 539 
Figure 2: Paraquat inhibits electrical field stimulated relaxations in murine distal colon. 540 
Sample traces of the force generated following a 30 s, 5 Hz stimulation of segments of 541 
distal colon maintained in Krebs buffer solution (Ai, Bi, Ci) or 20 mM paraquat  (Aii, Bii, 542 
Cii) in the presence and absence of either L-NNA (Bi, Bii) or scopolamine and 543 
GR159897 (Ci, Cii).  Frequency response curve illustrating that paraquat pre-treatment 544 
inhibits electrically evoked relaxation of the tissue (Aiii, Ciii) without affecting electrically 545 
evoked contractions (Biii).  N=5 for each group, * p<0.05; ** p<0.01; *** p<0.001. 546 
Figure 3: Effects of paraquat on the properties of colonic migrating motor complexes.  547 
Bar graphs illustrating the effects of paraquat on the amplitude (Ai, Bi); duration (Aii, 548 
Bii); frequency (C) and velocity (D) of CMMCs in isolated murine colon.   N=6 for all 549 
groups; *p<0.05; **p<0.01; ***p<0.001 versus control. 550 
Figure 4: Effects of paraquat on the properties of CMMCs are mimicked by inhibition of 551 
nitrergic signalling. Bar graphs illustrating the effects of L-NNA on the amplitude (Ai, Bi); 552 
duration (Aii, Bii); frequency (C) and velocity (D) of CMMCs in murine isolated colon. 553 
N=6 for all groups; *p<0.05; **p<0.01 versus control. 554 
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Figure 5:  Paraquat inhibits faecal pellet motility.  A) Traces illustrating typical distance 555 
time plots for the movement of an artificial faecal pellet through the intact but isolated 556 
colon.  Control traces are shown in black, while paraquat pre-treated tissue is shown in 557 
grey. B) Bar graph showing the population data for the velocity of pellet movement 558 
through the colon.  N=6 for each group; ** p<0.01 (Students T-test). 559 
Figure 6: Paraquat decreases NO release from the myenteric plexus.  A) Amperometric 560 
traces following application of 10µM veratridine to the distal colon myenteric plexus.  B) 561 
NO release is impaired following paraquat treatment. N=4 for each group; ** p<0.0001. 562 
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Supplementary Figure 1: Paraquat increases MDA levels in the mucosa but not distal 609 
colon smooth muscle. Bar graphs showing how MDA levels in both the mucosa (A) and 610 
smooth muscle (B) are affected by paraquat treatment. N=5 for each group; * p<0.05. 611 
 612 
 613 
Supplementary Figure 2: Paraquat does not alter expression of TNFalpha or complex 614 
1 in the distal colon.  Bar graphs illustrating the change in expression of TNFalpha (Ai, 615 
Aii), complex 1 (Bi, Bii).  N=5 per group. 616 
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